T cell repertoire following autologous stem cell transplantation for multiple sclerosis

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

(2013) Richard Nash et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation

(2013) Jeroen W J van Heijst et al.   NATURE MEDICINE

Immune reconstitution after hematopoietic cell transplantation

(2012) Mark Bosch et al.   CURRENT OPINION IN HEMATOLOGY

Deep Sequencing of Antiviral T-Cell Responses to HCMV and EBV in Humans Reveals a Stable Repertoire That Is Maintained for Many Years

(2012) P. L. Klarenbeek et al.   PLoS Pathogens

Quantitative tracking of T cell clones after haematopoietic stem cell transplantation

(2011) Ilgar Z. Mamedov et al.   EMBO Molecular Medicine

Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination

(2011) John J Miles et al.   IMMUNOLOGY AND CELL BIOLOGY

Comprehensive assessment of T-cell receptor  -chain diversity in    T cells

(2009) H. S. Robins et al.   BLOOD

T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft

(2009) A N Dubinsky et al.   BONE MARROW TRANSPLANTATION